China Pioneer Pharma To Invest $5.7 Million In NovaBay Pharmaceuticals, Inc. For Distribution Rights

by Richard Daverman, PhD

December 2, 2013 -- China Pioneer Pharma expanded its China distribution agreement with NovaBay Pharma, a California company that is developing non-antibiotic antimicrobial products. Pioneer will distribute two additional products in China and Southeast Asia for NovaBay. In return for these rights, Pioneer will purchase 5 million shares of NovaBay at a price of $5.7 million, replacing an earlier $3 million agreement. More details....

Stock Symbols: (HK: 1345) (NYSE: NBY)

Help employers find you! Check out all the jobs and post your resume.